Psychiatry & Neurology Doctors in Joplin, MO Accepting Medicare

42 Psychiatry & Neurology doctors found. Showing 21 - 40

Babar Shaikh, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Matthew Krahl, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Allison Smith, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7600    Fax: 417-347-7608

Tabassum Saba, MBBS Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7600    Fax: 417-347-7608

Ozge Williams, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Alexander Hunter, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Patience Mina Dikibo, PMHNP Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3230 Wisconsin Ave Ste A, Joplin, MO 64804 Phone: 417-347-7800

Dr. James Orlando Iii, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5615 W. 32nd, Joplin, MO 64804 Phone: 417-781-7337

Nauman Ashraf, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 347-221-3491    Fax: 417-347-9810

Anam Shamim, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Raghad Alkhafaji, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Barinder K Singh, DO Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-5800

Filomena Galdikas, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Ahmed Tm Robbie, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1905 W 32nd St, Ste 403, Joplin, MO 64804 Phone: 417-782-5500    Fax: 417-782-8516

Matthew King, DO Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603    Fax: 417-347-9810

Dr. Oscar H Gonzalez, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2509 Jackson Street, Joplin, MO 64804 Phone: 417-781-7792    Fax: 417-627-9980

Jeffrey Shane Bradley, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 530 E 34th St, Joplin, MO 64804 Phone: 417-347-7630

Dr. William Joseph Klontz, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5615 W 32nd St, Joplin, MO 64804 Phone: 417-627-8400    Fax: 417-623-1787

Areeb Usmani, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 932 E 34th St, Joplin, MO 64804 Phone: 417-347-7603

Maxwell Mcclure, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 305 S Virginia Ave, Joplin, MO 64801 Phone: 417-347-7731

News Archive

Independent SMB recommends continuance of Allovectin-7 Phase 3 trial for metastatic melanoma

Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fourth scheduled safety analysis and recommended that the trial continue per the protocol.

Forest Laboratories reports first-quarter diluted EPS of $0.39

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.39 in the first quarter of fiscal 2011. Excluding the charge related to the United States Department of Justice investigations described below, and a charge of $50.0 million, or $0.17 per share net of tax, for a new product licensing fee, non-GAAP earnings per share for the first fiscal quarter were $0.95 per share.

Researchers discover TTC7A gene that causes multiple intestinal atresia in newborns

Physicians and researchers from Sherbrooke, Montreal and Quebec City have conducted a study that has led to the discovery of a gene that causes multiple intestinal atresia (MIA), a rare and life-threatening hereditary disorder that affects newborns.

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols.

Scientist receives RO1 research grant to improve blood, marrow transplantation in myeloma patients

Thea Friedman, M.D., associate scientist and director of oncology basic research at the John Theurer Cancer Center at Hackensack University Medical Center was recently awarded a National Cancer Institutes of Health-National Cancer Institute RO1 research grant to improve allogeneic blood and marrow transplantation for multiple myeloma patients.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)
• 3